Table 1. .
Case Number |
Age (y) |
Sex |
Visual Acuity (VA) |
PRL Size* (degrees) |
|
OD |
OS |
||||
Controls | |||||
100 | 27 | M | 20/18 | 20/15 | |
101 | 22 | M | 20/17 | 20/16 | |
102 | 33 | F | 20/20 | 20/17 | |
103 | 23 | F | 20/20 | 20/20 | |
104 | 48 | M | 20/24 | 20/24 | NA |
200 | 70 | M | 20/21 | 20/20 | |
201 | 63 | M | 20/25 | 20/24 | |
202 | 61 | M | 20/22 | 20/20 | |
203 | 54 | F | 20/24 | 20/24 | |
204 | 65 | F | 20/20 | 20/20 | |
Patients | |||||
300 | 44 | F | 20/60 | 20/32 | 12 (OS) |
301 | 55 | F | 20/400 | 20/450 | 9 (OD) |
400 | 64 | M | 20/76 | 20/91 | 12 (OD) |
401 | 77 | F | 20/121 | 20/166 | 6 (OD) |
402 | 82 | F | 20/320 | 20/560 | 3 (OD) |
100 to 104: Younger normally sighted control subjects; 200 to 204: Older normally sighted control subjects; 300 to 301: Patients with macular degeneration due to Stargardt disease; 400 to 402: Patients with age-related macular degeneration. PRL, Preferred Retinal Locus; NA, not applicable.
* The PRL size for the better eye is shown.